Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking Cessation | 77 | 2025 | 2084 | 9.260 |
Why?
|
Neoplasms | 96 | 2024 | 22340 | 4.080 |
Why?
|
Resilience, Psychological | 13 | 2024 | 806 | 3.810 |
Why?
|
Smoking | 48 | 2023 | 9081 | 3.800 |
Why?
|
Mind-Body Therapies | 14 | 2024 | 294 | 3.250 |
Why?
|
Survivors | 36 | 2024 | 2372 | 2.860 |
Why?
|
Lung Neoplasms | 51 | 2024 | 13451 | 2.760 |
Why?
|
Stress, Psychological | 28 | 2022 | 4533 | 2.530 |
Why?
|
Health Behavior | 24 | 2023 | 2650 | 2.410 |
Why?
|
Insurance, Health | 17 | 2024 | 2521 | 2.330 |
Why?
|
Insurance Coverage | 14 | 2024 | 1944 | 2.290 |
Why?
|
Early Detection of Cancer | 22 | 2024 | 3236 | 2.240 |
Why?
|
Patient Protection and Affordable Care Act | 11 | 2024 | 1188 | 2.010 |
Why?
|
Relaxation Therapy | 6 | 2018 | 180 | 1.920 |
Why?
|
Counseling | 20 | 2022 | 1551 | 1.910 |
Why?
|
Fear | 7 | 2024 | 1499 | 1.810 |
Why?
|
Adaptation, Psychological | 25 | 2024 | 2660 | 1.760 |
Why?
|
Attitude to Health | 16 | 2020 | 2020 | 1.590 |
Why?
|
Quality of Life | 51 | 2024 | 13462 | 1.380 |
Why?
|
Pilot Projects | 34 | 2024 | 8733 | 1.370 |
Why?
|
Depression | 28 | 2023 | 8237 | 1.290 |
Why?
|
Tobacco Use Disorder | 6 | 2019 | 708 | 1.220 |
Why?
|
Health Knowledge, Attitudes, Practice | 18 | 2024 | 4058 | 1.200 |
Why?
|
Health Services Accessibility | 11 | 2019 | 5508 | 1.200 |
Why?
|
Neurofibromatosis 1 | 6 | 2015 | 560 | 1.180 |
Why?
|
Telephone | 12 | 2025 | 627 | 1.140 |
Why?
|
Female | 230 | 2025 | 396112 | 1.100 |
Why?
|
Mind-Body Relations, Metaphysical | 3 | 2016 | 34 | 1.100 |
Why?
|
Tobacco Use Cessation | 3 | 2022 | 100 | 1.070 |
Why?
|
Humans | 311 | 2025 | 765968 | 1.060 |
Why?
|
Body Image | 4 | 2020 | 644 | 1.040 |
Why?
|
Acute Coronary Syndrome | 6 | 2021 | 2184 | 1.030 |
Why?
|
Social Stigma | 4 | 2021 | 788 | 1.010 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2024 | 9373 | 0.990 |
Why?
|
Middle Aged | 152 | 2025 | 223009 | 0.990 |
Why?
|
Cultural Diversity | 7 | 2010 | 370 | 0.980 |
Why?
|
Psychotherapy, Group | 3 | 2020 | 416 | 0.970 |
Why?
|
Qualitative Research | 27 | 2024 | 3139 | 0.960 |
Why?
|
Palliative Care | 20 | 2022 | 3645 | 0.960 |
Why?
|
Mass Chest X-Ray | 3 | 2015 | 18 | 0.950 |
Why?
|
Male | 185 | 2025 | 363698 | 0.940 |
Why?
|
Attitude of Health Personnel | 14 | 2020 | 3925 | 0.940 |
Why?
|
Program Development | 5 | 2024 | 1295 | 0.900 |
Why?
|
Siblings | 11 | 2024 | 828 | 0.880 |
Why?
|
Health Communication | 2 | 2018 | 216 | 0.880 |
Why?
|
Adult | 138 | 2025 | 223044 | 0.880 |
Why?
|
Gastrointestinal Neoplasms | 11 | 2018 | 961 | 0.870 |
Why?
|
Relaxation | 2 | 2014 | 51 | 0.870 |
Why?
|
Telemedicine | 8 | 2022 | 3105 | 0.860 |
Why?
|
Self Efficacy | 5 | 2018 | 642 | 0.850 |
Why?
|
Neurofibromatosis 2 | 4 | 2014 | 387 | 0.840 |
Why?
|
Psychological Tests | 2 | 2023 | 644 | 0.820 |
Why?
|
Parents | 5 | 2020 | 3592 | 0.820 |
Why?
|
Motivation | 14 | 2020 | 2018 | 0.800 |
Why?
|
Anxiety | 16 | 2022 | 4671 | 0.800 |
Why?
|
Physician-Patient Relations | 9 | 2016 | 3278 | 0.770 |
Why?
|
Colorectal Neoplasms | 8 | 2024 | 6942 | 0.760 |
Why?
|
Breast Neoplasms | 19 | 2024 | 21056 | 0.730 |
Why?
|
Interviews as Topic | 16 | 2020 | 2739 | 0.730 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2024 | 1090 | 0.730 |
Why?
|
Social Support | 12 | 2020 | 2192 | 0.710 |
Why?
|
Temperance | 1 | 2020 | 88 | 0.700 |
Why?
|
Healthcare Disparities | 7 | 2023 | 3413 | 0.700 |
Why?
|
Appointments and Schedules | 2 | 2024 | 444 | 0.690 |
Why?
|
Feasibility Studies | 18 | 2024 | 5302 | 0.680 |
Why?
|
Substance-Related Disorders | 5 | 2023 | 4416 | 0.670 |
Why?
|
Self Report | 5 | 2023 | 3770 | 0.650 |
Why?
|
Primary Health Care | 15 | 2021 | 4736 | 0.650 |
Why?
|
Aged | 90 | 2024 | 171117 | 0.640 |
Why?
|
Cross-Sectional Studies | 29 | 2024 | 26318 | 0.640 |
Why?
|
Mass Screening | 11 | 2021 | 5446 | 0.630 |
Why?
|
Focus Groups | 15 | 2018 | 1459 | 0.610 |
Why?
|
Perception | 6 | 2020 | 1205 | 0.610 |
Why?
|
Personnel, Hospital | 1 | 2020 | 286 | 0.600 |
Why?
|
Cancer Care Facilities | 4 | 2018 | 426 | 0.600 |
Why?
|
Neurofibromatoses | 4 | 2016 | 303 | 0.600 |
Why?
|
Psychotherapy | 4 | 2023 | 1645 | 0.580 |
Why?
|
Employment | 5 | 2018 | 1106 | 0.570 |
Why?
|
Family Practice | 6 | 2016 | 508 | 0.570 |
Why?
|
Nursing Methodology Research | 1 | 2017 | 63 | 0.560 |
Why?
|
Infertility, Female | 2 | 2014 | 763 | 0.560 |
Why?
|
Advance Care Planning | 4 | 2021 | 702 | 0.560 |
Why?
|
Mammography | 7 | 2024 | 2423 | 0.550 |
Why?
|
Translating | 3 | 2016 | 144 | 0.540 |
Why?
|
Cost of Illness | 8 | 2024 | 1950 | 0.530 |
Why?
|
Hospitals, General | 2 | 2020 | 802 | 0.530 |
Why?
|
Self Care | 5 | 2022 | 800 | 0.520 |
Why?
|
Health Care Costs | 6 | 2017 | 3242 | 0.520 |
Why?
|
United States | 48 | 2024 | 72903 | 0.510 |
Why?
|
Medically Uninsured | 6 | 2024 | 838 | 0.510 |
Why?
|
Emotions | 8 | 2023 | 2763 | 0.510 |
Why?
|
Mental Health Services | 3 | 2018 | 1723 | 0.500 |
Why?
|
Patient Acceptance of Health Care | 9 | 2020 | 3230 | 0.500 |
Why?
|
Autistic Disorder | 3 | 2021 | 1239 | 0.490 |
Why?
|
Health Services Needs and Demand | 6 | 2020 | 1406 | 0.490 |
Why?
|
Postpartum Period | 5 | 2021 | 1205 | 0.480 |
Why?
|
Insurance, Disability | 1 | 2015 | 26 | 0.480 |
Why?
|
Models, Nursing | 1 | 2015 | 46 | 0.470 |
Why?
|
Exercise | 9 | 2020 | 5937 | 0.470 |
Why?
|
Endocarditis | 1 | 2019 | 350 | 0.470 |
Why?
|
Disabled Persons | 3 | 2015 | 1208 | 0.470 |
Why?
|
Self Concept | 3 | 2013 | 1037 | 0.470 |
Why?
|
Social Security | 1 | 2015 | 103 | 0.470 |
Why?
|
Patient Compliance | 5 | 2024 | 2692 | 0.460 |
Why?
|
Neurilemmoma | 3 | 2014 | 522 | 0.460 |
Why?
|
Caregivers | 9 | 2023 | 2307 | 0.450 |
Why?
|
Consensus | 1 | 2024 | 3202 | 0.450 |
Why?
|
Communication | 6 | 2021 | 3916 | 0.450 |
Why?
|
Uncertainty | 2 | 2022 | 761 | 0.440 |
Why?
|
Loneliness | 2 | 2013 | 211 | 0.440 |
Why?
|
Mental Disorders | 8 | 2023 | 6853 | 0.440 |
Why?
|
Sexual Behavior | 3 | 2018 | 2193 | 0.440 |
Why?
|
Health Personnel | 6 | 2019 | 3390 | 0.430 |
Why?
|
Physicians, Family | 4 | 2009 | 349 | 0.430 |
Why?
|
Internal Medicine | 6 | 2016 | 1064 | 0.430 |
Why?
|
Sexual Dysfunction, Physiological | 3 | 2018 | 363 | 0.430 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2015 | 170 | 0.420 |
Why?
|
Internship and Residency | 10 | 2010 | 5946 | 0.420 |
Why?
|
Postnatal Care | 1 | 2015 | 275 | 0.420 |
Why?
|
Young Adult | 34 | 2024 | 59889 | 0.410 |
Why?
|
Research Design | 7 | 2017 | 6209 | 0.410 |
Why?
|
Social Perception | 2 | 2015 | 436 | 0.410 |
Why?
|
Follow-Up Studies | 20 | 2024 | 39193 | 0.410 |
Why?
|
Cultural Competency | 3 | 2010 | 303 | 0.410 |
Why?
|
Delivery of Health Care | 8 | 2020 | 5370 | 0.410 |
Why?
|
Community Health Services | 3 | 2012 | 657 | 0.400 |
Why?
|
Nicotinic Agonists | 3 | 2017 | 266 | 0.400 |
Why?
|
Communication Barriers | 4 | 2016 | 418 | 0.400 |
Why?
|
Continuity of Patient Care | 4 | 2024 | 1078 | 0.400 |
Why?
|
Socioeconomic Factors | 12 | 2024 | 7838 | 0.400 |
Why?
|
Child | 32 | 2024 | 80564 | 0.390 |
Why?
|
Decision Making | 7 | 2018 | 3965 | 0.390 |
Why?
|
Headache | 2 | 2018 | 1259 | 0.380 |
Why?
|
Culture | 2 | 2015 | 622 | 0.380 |
Why?
|
Physician's Role | 3 | 2009 | 927 | 0.370 |
Why?
|
Lymphoma | 1 | 2020 | 1897 | 0.370 |
Why?
|
Medical Oncology | 7 | 2023 | 2339 | 0.370 |
Why?
|
Mothers | 5 | 2009 | 2210 | 0.360 |
Why?
|
Ambulatory Care Facilities | 1 | 2016 | 939 | 0.340 |
Why?
|
Boston | 12 | 2019 | 9338 | 0.340 |
Why?
|
Practice Guidelines as Topic | 6 | 2024 | 7425 | 0.340 |
Why?
|
Massachusetts | 15 | 2024 | 8875 | 0.340 |
Why?
|
Patient Education as Topic | 5 | 2018 | 2334 | 0.340 |
Why?
|
Mobility Limitation | 2 | 2010 | 408 | 0.330 |
Why?
|
Patient-Centered Care | 3 | 2019 | 1458 | 0.330 |
Why?
|
Health Literacy | 3 | 2022 | 464 | 0.330 |
Why?
|
Health Benefit Plans, Employee | 1 | 2012 | 331 | 0.330 |
Why?
|
Pregnant Women | 2 | 2021 | 575 | 0.330 |
Why?
|
Guideline Adherence | 2 | 2018 | 2243 | 0.320 |
Why?
|
Adolescent | 33 | 2024 | 88835 | 0.320 |
Why?
|
Comprehension | 1 | 2015 | 638 | 0.320 |
Why?
|
Lung | 6 | 2022 | 10033 | 0.320 |
Why?
|
Quinoxalines | 1 | 2011 | 296 | 0.320 |
Why?
|
Chronic Disease | 5 | 2020 | 9347 | 0.320 |
Why?
|
Race Relations | 2 | 2006 | 35 | 0.320 |
Why?
|
Benzazepines | 1 | 2011 | 308 | 0.320 |
Why?
|
Burnout, Professional | 2 | 2015 | 711 | 0.320 |
Why?
|
Health Care Surveys | 10 | 2018 | 2424 | 0.310 |
Why?
|
Health Promotion | 5 | 2018 | 2208 | 0.310 |
Why?
|
Opioid-Related Disorders | 3 | 2022 | 2178 | 0.310 |
Why?
|
Medication Adherence | 10 | 2024 | 2192 | 0.310 |
Why?
|
Cross-Cultural Comparison | 2 | 2009 | 634 | 0.310 |
Why?
|
Truth Disclosure | 1 | 2012 | 433 | 0.310 |
Why?
|
Terminal Care | 7 | 2020 | 1774 | 0.300 |
Why?
|
Clinical Competence | 6 | 2009 | 4863 | 0.300 |
Why?
|
Mental Health | 8 | 2023 | 3278 | 0.300 |
Why?
|
Behavior Therapy | 3 | 2022 | 884 | 0.300 |
Why?
|
Nicotine | 4 | 2008 | 682 | 0.290 |
Why?
|
Grief | 2 | 2022 | 255 | 0.290 |
Why?
|
Income | 3 | 2019 | 1874 | 0.290 |
Why?
|
Physicians, Primary Care | 3 | 2020 | 622 | 0.290 |
Why?
|
Quality of Health Care | 5 | 2017 | 4300 | 0.290 |
Why?
|
Sexual Partners | 1 | 2012 | 804 | 0.290 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2020 | 12240 | 0.280 |
Why?
|
HIV Seropositivity | 1 | 2012 | 961 | 0.280 |
Why?
|
Risk Assessment | 13 | 2019 | 24282 | 0.270 |
Why?
|
Sexuality | 1 | 2009 | 180 | 0.270 |
Why?
|
Documentation | 4 | 2022 | 916 | 0.270 |
Why?
|
Patient Participation | 4 | 2020 | 1455 | 0.270 |
Why?
|
Hydrocortisone | 1 | 2014 | 1827 | 0.270 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 916 | 0.260 |
Why?
|
Aging | 2 | 2022 | 8731 | 0.260 |
Why?
|
Clinical Protocols | 1 | 2012 | 1441 | 0.250 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2310 | 0.250 |
Why?
|
Family | 5 | 2023 | 3209 | 0.250 |
Why?
|
Intention | 2 | 2019 | 346 | 0.250 |
Why?
|
Behavior, Addictive | 1 | 2011 | 423 | 0.250 |
Why?
|
Randomized Controlled Trials as Topic | 11 | 2022 | 10383 | 0.250 |
Why?
|
Program Evaluation | 8 | 2020 | 2499 | 0.250 |
Why?
|
Pediatrics | 9 | 2017 | 3606 | 0.250 |
Why?
|
Pain | 4 | 2022 | 5077 | 0.240 |
Why?
|
Biomedical Research | 1 | 2020 | 3458 | 0.240 |
Why?
|
Clinical Trials as Topic | 5 | 2023 | 8041 | 0.240 |
Why?
|
Community Health Centers | 3 | 2024 | 469 | 0.240 |
Why?
|
Depressive Disorder | 4 | 2016 | 3714 | 0.240 |
Why?
|
Hospice Care | 3 | 2020 | 678 | 0.230 |
Why?
|
Depression, Postpartum | 1 | 2009 | 360 | 0.230 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2009 | 624 | 0.230 |
Why?
|
Breast | 1 | 2013 | 1946 | 0.220 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2024 | 5753 | 0.220 |
Why?
|
Internet | 2 | 2016 | 3106 | 0.220 |
Why?
|
Bupropion | 2 | 2020 | 303 | 0.220 |
Why?
|
Child, Preschool | 12 | 2024 | 42500 | 0.210 |
Why?
|
Patient Selection | 3 | 2023 | 4255 | 0.210 |
Why?
|
Schizophrenia | 2 | 2019 | 6972 | 0.210 |
Why?
|
Cost-Benefit Analysis | 5 | 2022 | 5526 | 0.210 |
Why?
|
Prenatal Care | 3 | 2008 | 1160 | 0.210 |
Why?
|
Professional Competence | 2 | 2008 | 429 | 0.210 |
Why?
|
HIV Infections | 4 | 2022 | 17533 | 0.200 |
Why?
|
Tobacco Smoke Pollution | 3 | 2015 | 827 | 0.200 |
Why?
|
Schools | 1 | 2011 | 1492 | 0.200 |
Why?
|
Tobacco, Smokeless | 1 | 2023 | 132 | 0.200 |
Why?
|
Chemotherapy, Adjuvant | 7 | 2024 | 3537 | 0.200 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 2033 | 0.190 |
Why?
|
Veterans | 3 | 2021 | 2664 | 0.190 |
Why?
|
Treatment Outcome | 17 | 2023 | 65188 | 0.190 |
Why?
|
Health Expenditures | 4 | 2024 | 2387 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 7 | 2024 | 20659 | 0.190 |
Why?
|
Skin Neoplasms | 4 | 2014 | 5849 | 0.190 |
Why?
|
Models, Psychological | 2 | 2003 | 824 | 0.190 |
Why?
|
Patient Discharge | 6 | 2018 | 3461 | 0.190 |
Why?
|
Prospective Studies | 14 | 2024 | 54802 | 0.180 |
Why?
|
Managed Care Programs | 1 | 2007 | 934 | 0.180 |
Why?
|
Cotinine | 2 | 2020 | 206 | 0.180 |
Why?
|
Eligibility Determination | 2 | 2019 | 423 | 0.170 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2018 | 953 | 0.170 |
Why?
|
Social Justice | 1 | 2005 | 485 | 0.170 |
Why?
|
Postal Service | 1 | 2020 | 96 | 0.170 |
Why?
|
Anxiety Disorders | 3 | 2021 | 2737 | 0.170 |
Why?
|
Genetic Counseling | 3 | 2012 | 634 | 0.170 |
Why?
|
Recurrence | 5 | 2015 | 8501 | 0.170 |
Why?
|
Aged, 80 and over | 17 | 2022 | 59489 | 0.170 |
Why?
|
Unemployment | 2 | 2012 | 211 | 0.160 |
Why?
|
Sex Factors | 5 | 2019 | 10603 | 0.160 |
Why?
|
Electronic Health Records | 7 | 2022 | 4873 | 0.160 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14751 | 0.160 |
Why?
|
Surgical Procedures, Operative | 1 | 2010 | 1941 | 0.160 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2020 | 137 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2018 | 5389 | 0.160 |
Why?
|
Needs Assessment | 4 | 2020 | 1138 | 0.160 |
Why?
|
Outpatients | 3 | 2022 | 1595 | 0.150 |
Why?
|
Affect | 5 | 2018 | 1500 | 0.150 |
Why?
|
Head and Neck Neoplasms | 2 | 2024 | 2921 | 0.150 |
Why?
|
Meditation | 2 | 2020 | 256 | 0.150 |
Why?
|
Habits | 2 | 2020 | 147 | 0.150 |
Why?
|
Prisoners | 1 | 2021 | 316 | 0.150 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 3110 | 0.150 |
Why?
|
Patient Satisfaction | 4 | 2020 | 3475 | 0.150 |
Why?
|
Medicaid | 2 | 2024 | 2833 | 0.150 |
Why?
|
Directive Counseling | 2 | 2017 | 171 | 0.140 |
Why?
|
Interpersonal Relations | 2 | 2017 | 1432 | 0.140 |
Why?
|
Widowhood | 1 | 2017 | 51 | 0.140 |
Why?
|
Ambulatory Care | 3 | 2022 | 2778 | 0.140 |
Why?
|
Professional-Patient Relations | 4 | 2018 | 721 | 0.140 |
Why?
|
Disabled Children | 1 | 2020 | 250 | 0.140 |
Why?
|
Vulnerable Populations | 1 | 2023 | 718 | 0.140 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1731 | 0.140 |
Why?
|
Prescription Fees | 1 | 2018 | 153 | 0.140 |
Why?
|
Financing, Personal | 1 | 2019 | 310 | 0.130 |
Why?
|
Hospices | 1 | 2019 | 245 | 0.130 |
Why?
|
Psychometrics | 4 | 2021 | 3062 | 0.130 |
Why?
|
Medicare | 3 | 2024 | 6823 | 0.130 |
Why?
|
Confidentiality | 1 | 2020 | 607 | 0.130 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2019 | 276 | 0.130 |
Why?
|
Logistic Models | 7 | 2017 | 13266 | 0.130 |
Why?
|
Health Services Research | 2 | 2013 | 1808 | 0.130 |
Why?
|
Comorbidity | 5 | 2019 | 10563 | 0.130 |
Why?
|
Risk | 3 | 2018 | 9591 | 0.130 |
Why?
|
Age of Onset | 2 | 2018 | 3344 | 0.130 |
Why?
|
Language | 2 | 2016 | 1550 | 0.130 |
Why?
|
Internal-External Control | 2 | 2011 | 347 | 0.130 |
Why?
|
Women | 2 | 2012 | 226 | 0.130 |
Why?
|
Moral Obligations | 1 | 2016 | 91 | 0.130 |
Why?
|
Saliva | 1 | 2020 | 851 | 0.130 |
Why?
|
Social Class | 1 | 2024 | 2007 | 0.130 |
Why?
|
Deception | 1 | 2016 | 99 | 0.130 |
Why?
|
Phobic Disorders | 1 | 2018 | 440 | 0.120 |
Why?
|
Parent-Child Relations | 2 | 2019 | 774 | 0.120 |
Why?
|
Retrospective Studies | 9 | 2023 | 81514 | 0.120 |
Why?
|
Patient Care Team | 3 | 2015 | 2517 | 0.120 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 622 | 0.120 |
Why?
|
Waiting Lists | 1 | 2020 | 777 | 0.120 |
Why?
|
Affective Symptoms | 2 | 2022 | 417 | 0.120 |
Why?
|
Data Collection | 6 | 2009 | 3318 | 0.120 |
Why?
|
Rhode Island | 4 | 2003 | 351 | 0.120 |
Why?
|
Rectal Neoplasms | 1 | 2024 | 1182 | 0.120 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2020 | 3719 | 0.120 |
Why?
|
Prognosis | 9 | 2021 | 29922 | 0.120 |
Why?
|
Pregnancy Complications | 2 | 2021 | 2975 | 0.120 |
Why?
|
Combined Modality Therapy | 5 | 2022 | 8529 | 0.120 |
Why?
|
Bereavement | 1 | 2019 | 308 | 0.120 |
Why?
|
Antineoplastic Agents, Hormonal | 4 | 2024 | 1534 | 0.120 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2017 | 6014 | 0.120 |
Why?
|
Patients | 2 | 2019 | 910 | 0.110 |
Why?
|
Buprenorphine | 1 | 2022 | 665 | 0.110 |
Why?
|
Cohort Studies | 9 | 2019 | 41649 | 0.110 |
Why?
|
Physicians | 2 | 2003 | 4588 | 0.110 |
Why?
|
Reminder Systems | 1 | 2017 | 388 | 0.110 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6364 | 0.110 |
Why?
|
Comparative Effectiveness Research | 2 | 2016 | 714 | 0.110 |
Why?
|
Neoplasm Staging | 4 | 2024 | 11206 | 0.110 |
Why?
|
Age Factors | 5 | 2019 | 18380 | 0.110 |
Why?
|
Neoplasms, Second Primary | 2 | 2015 | 1050 | 0.110 |
Why?
|
Hospitalization | 5 | 2019 | 10808 | 0.110 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9071 | 0.110 |
Why?
|
Social Control, Informal | 1 | 2013 | 44 | 0.110 |
Why?
|
Environment Design | 1 | 2014 | 174 | 0.100 |
Why?
|
Infant, Newborn | 4 | 2018 | 26346 | 0.100 |
Why?
|
Genetic Testing | 5 | 2012 | 3595 | 0.100 |
Why?
|
Infant | 5 | 2024 | 36386 | 0.100 |
Why?
|
Travel | 1 | 2019 | 806 | 0.100 |
Why?
|
Interdisciplinary Communication | 1 | 2018 | 932 | 0.100 |
Why?
|
Empirical Research | 1 | 2013 | 119 | 0.100 |
Why?
|
Peer Group | 3 | 2022 | 701 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1668 | 0.100 |
Why?
|
Risk Factors | 12 | 2020 | 74840 | 0.100 |
Why?
|
Cranial Irradiation | 1 | 2015 | 385 | 0.100 |
Why?
|
Decision Support Techniques | 2 | 2020 | 2003 | 0.100 |
Why?
|
Pregnancy | 9 | 2021 | 30260 | 0.100 |
Why?
|
Allostasis | 1 | 2013 | 76 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 4 | 2016 | 18071 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2024 | 2412 | 0.100 |
Why?
|
Professional Role | 1 | 2014 | 313 | 0.090 |
Why?
|
Hypertension | 1 | 2012 | 8626 | 0.090 |
Why?
|
Principal Component Analysis | 1 | 2015 | 951 | 0.090 |
Why?
|
Awareness | 2 | 2015 | 653 | 0.090 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1519 | 0.090 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 1315 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20124 | 0.090 |
Why?
|
Staff Development | 1 | 2013 | 230 | 0.090 |
Why?
|
Activities of Daily Living | 2 | 2010 | 2415 | 0.090 |
Why?
|
Obstetrics | 3 | 2008 | 680 | 0.090 |
Why?
|
Ethics, Medical | 1 | 2016 | 783 | 0.090 |
Why?
|
Terminology as Topic | 1 | 2018 | 1534 | 0.090 |
Why?
|
Tomography, Spiral Computed | 1 | 2012 | 273 | 0.090 |
Why?
|
Oncology Service, Hospital | 1 | 2011 | 55 | 0.090 |
Why?
|
Clinical Coding | 1 | 2013 | 190 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2015 | 499 | 0.090 |
Why?
|
Alabama | 1 | 2011 | 111 | 0.090 |
Why?
|
Geriatrics | 1 | 2015 | 396 | 0.090 |
Why?
|
Heart Failure | 3 | 2020 | 11840 | 0.090 |
Why?
|
Professional-Family Relations | 1 | 2015 | 501 | 0.090 |
Why?
|
Interior Design and Furnishings | 1 | 2010 | 34 | 0.090 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15880 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2020 | 1799 | 0.090 |
Why?
|
Withholding Treatment | 1 | 2015 | 621 | 0.090 |
Why?
|
Self Administration | 1 | 2012 | 385 | 0.090 |
Why?
|
Maryland | 1 | 2011 | 278 | 0.090 |
Why?
|
Students | 1 | 2020 | 1734 | 0.090 |
Why?
|
Environment | 1 | 2016 | 1114 | 0.090 |
Why?
|
Teaching | 1 | 2017 | 1169 | 0.080 |
Why?
|
Coronary Disease | 2 | 2015 | 5912 | 0.080 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 350 | 0.080 |
Why?
|
Medication Errors | 1 | 2016 | 786 | 0.080 |
Why?
|
Pandemics | 4 | 2023 | 8703 | 0.080 |
Why?
|
Self-Examination | 1 | 2009 | 72 | 0.080 |
Why?
|
Time Factors | 9 | 2018 | 40065 | 0.080 |
Why?
|
Research | 1 | 2017 | 1975 | 0.080 |
Why?
|
Military Personnel | 1 | 2018 | 1252 | 0.080 |
Why?
|
Multivariate Analysis | 4 | 2013 | 12056 | 0.080 |
Why?
|
Education, Professional | 1 | 2009 | 53 | 0.080 |
Why?
|
Health Status | 3 | 2017 | 4080 | 0.080 |
Why?
|
Health Surveys | 2 | 2017 | 4056 | 0.080 |
Why?
|
Overweight | 3 | 2014 | 2444 | 0.080 |
Why?
|
Advance Directive Adherence | 1 | 2008 | 20 | 0.080 |
Why?
|
Occupations | 1 | 2011 | 516 | 0.080 |
Why?
|
Referral and Consultation | 3 | 2012 | 3615 | 0.070 |
Why?
|
Yoga | 1 | 2011 | 277 | 0.070 |
Why?
|
Personal Satisfaction | 1 | 2012 | 641 | 0.070 |
Why?
|
Risk-Taking | 2 | 2004 | 1021 | 0.070 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1884 | 0.070 |
Why?
|
Attitude | 1 | 2012 | 770 | 0.070 |
Why?
|
Patient Preference | 1 | 2014 | 952 | 0.070 |
Why?
|
Designer Drugs | 1 | 2007 | 21 | 0.070 |
Why?
|
Administration, Oral | 2 | 2015 | 4015 | 0.070 |
Why?
|
Checklist | 1 | 2014 | 848 | 0.070 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2011 | 597 | 0.070 |
Why?
|
Efficiency, Organizational | 1 | 2011 | 697 | 0.070 |
Why?
|
Organizational Policy | 1 | 2009 | 434 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3956 | 0.070 |
Why?
|
Education, Continuing | 1 | 2007 | 115 | 0.060 |
Why?
|
Odds Ratio | 5 | 2015 | 9649 | 0.060 |
Why?
|
Maternal Behavior | 1 | 2008 | 306 | 0.060 |
Why?
|
Parenting | 1 | 2012 | 709 | 0.060 |
Why?
|
Sleep | 1 | 2021 | 4813 | 0.060 |
Why?
|
Multilingualism | 1 | 2006 | 86 | 0.060 |
Why?
|
Child Behavior | 1 | 2011 | 865 | 0.060 |
Why?
|
Self-Evaluation Programs | 1 | 2005 | 28 | 0.060 |
Why?
|
Women's Health | 1 | 2015 | 2084 | 0.060 |
Why?
|
Least-Squares Analysis | 1 | 2006 | 368 | 0.060 |
Why?
|
Diabetes, Gestational | 1 | 2015 | 1263 | 0.060 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 2047 | 0.060 |
Why?
|
Incidence | 3 | 2019 | 21480 | 0.060 |
Why?
|
Academic Medical Centers | 3 | 2016 | 2780 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4808 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12795 | 0.060 |
Why?
|
Thoracic Surgery | 1 | 2011 | 728 | 0.060 |
Why?
|
Educational Status | 4 | 2017 | 2513 | 0.060 |
Why?
|
Poverty | 2 | 2015 | 2714 | 0.060 |
Why?
|
Child Welfare | 1 | 2008 | 521 | 0.060 |
Why?
|
Demography | 2 | 2006 | 1641 | 0.060 |
Why?
|
Attitude to Computers | 1 | 2005 | 196 | 0.060 |
Why?
|
Radiotherapy | 1 | 2010 | 1494 | 0.050 |
Why?
|
Utah | 2 | 2014 | 130 | 0.050 |
Why?
|
Stereotyping | 1 | 2005 | 242 | 0.050 |
Why?
|
Insurance, Dental | 1 | 2024 | 65 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3655 | 0.050 |
Why?
|
Population Surveillance | 1 | 2013 | 2590 | 0.050 |
Why?
|
Pleasure | 1 | 2023 | 41 | 0.050 |
Why?
|
Health Care Reform | 1 | 2012 | 1259 | 0.050 |
Why?
|
Gynecology | 2 | 2007 | 535 | 0.050 |
Why?
|
Delivery, Obstetric | 1 | 2010 | 946 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3835 | 0.050 |
Why?
|
Inpatients | 1 | 2014 | 2564 | 0.050 |
Why?
|
Curriculum | 2 | 2017 | 3782 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2020 | 4628 | 0.050 |
Why?
|
Azathioprine | 1 | 2023 | 350 | 0.050 |
Why?
|
Disease Progression | 2 | 2016 | 13632 | 0.050 |
Why?
|
Health Education | 1 | 2008 | 1060 | 0.050 |
Why?
|
Sibling Relations | 1 | 2021 | 46 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2023 | 299 | 0.050 |
Why?
|
Spouses | 1 | 2023 | 288 | 0.050 |
Why?
|
Task Performance and Analysis | 1 | 2005 | 770 | 0.040 |
Why?
|
Prevalence | 6 | 2020 | 15842 | 0.040 |
Why?
|
Efficiency | 1 | 2024 | 480 | 0.040 |
Why?
|
Nursing Homes | 1 | 2008 | 1084 | 0.040 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2022 | 283 | 0.040 |
Why?
|
Life Style | 3 | 2012 | 3926 | 0.040 |
Why?
|
Residence Characteristics | 2 | 2024 | 2116 | 0.040 |
Why?
|
Blood Pressure | 2 | 2014 | 8532 | 0.040 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1927 | 0.040 |
Why?
|
End Stage Liver Disease | 1 | 2024 | 369 | 0.040 |
Why?
|
Heart Diseases | 1 | 2012 | 2821 | 0.040 |
Why?
|
Hodgkin Disease | 1 | 2007 | 1383 | 0.040 |
Why?
|
Tape Recording | 1 | 2018 | 78 | 0.040 |
Why?
|
Sickness Impact Profile | 1 | 2020 | 297 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2010 | 6832 | 0.040 |
Why?
|
Medical Records Systems, Computerized | 1 | 2005 | 1195 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2005 | 1405 | 0.040 |
Why?
|
Linear Models | 3 | 2016 | 5876 | 0.040 |
Why?
|
Weight Gain | 1 | 2008 | 2355 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6544 | 0.040 |
Why?
|
Marital Status | 2 | 2010 | 426 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 7049 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 1999 | 0.030 |
Why?
|
Drug Tolerance | 1 | 2019 | 363 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 995 | 0.030 |
Why?
|
Speech Recognition Software | 1 | 2017 | 74 | 0.030 |
Why?
|
Genital Neoplasms, Female | 1 | 2002 | 533 | 0.030 |
Why?
|
Reward | 1 | 2023 | 981 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2418 | 0.030 |
Why?
|
Baltimore | 1 | 2016 | 232 | 0.030 |
Why?
|
Probability | 3 | 2008 | 2475 | 0.030 |
Why?
|
Alleles | 1 | 2007 | 6897 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22223 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2024 | 4860 | 0.030 |
Why?
|
Government Programs | 1 | 2017 | 278 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1207 | 0.030 |
Why?
|
Universities | 1 | 2020 | 998 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11083 | 0.030 |
Why?
|
Quality Assurance, Health Care | 1 | 2005 | 2172 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2014 | 208 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11868 | 0.030 |
Why?
|
Videoconferencing | 1 | 2016 | 209 | 0.030 |
Why?
|
American Cancer Society | 1 | 2014 | 69 | 0.030 |
Why?
|
Feeding Behavior | 2 | 2004 | 3212 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2015 | 573 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2010 | 2910 | 0.030 |
Why?
|
Nursing Evaluation Research | 1 | 2013 | 24 | 0.030 |
Why?
|
Pennsylvania | 1 | 2015 | 614 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1755 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2015 | 4893 | 0.030 |
Why?
|
Community-Institutional Relations | 1 | 2015 | 209 | 0.030 |
Why?
|
Quality Indicators, Health Care | 1 | 2003 | 1806 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2016 | 1589 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2015 | 955 | 0.030 |
Why?
|
Risk Management | 1 | 2016 | 559 | 0.020 |
Why?
|
Dance Therapy | 1 | 2011 | 8 | 0.020 |
Why?
|
Aftercare | 1 | 2018 | 911 | 0.020 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2013 | 212 | 0.020 |
Why?
|
Social Work | 1 | 2013 | 158 | 0.020 |
Why?
|
Automation | 1 | 2014 | 585 | 0.020 |
Why?
|
Social Marketing | 1 | 2011 | 51 | 0.020 |
Why?
|
Family Health | 1 | 2016 | 1253 | 0.020 |
Why?
|
Menopause | 1 | 2020 | 1659 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2017 | 906 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1509 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2013 | 297 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2721 | 0.020 |
Why?
|
Electronic Mail | 1 | 2013 | 216 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2013 | 394 | 0.020 |
Why?
|
Melanoma | 1 | 2009 | 5719 | 0.020 |
Why?
|
Incidental Findings | 1 | 2016 | 697 | 0.020 |
Why?
|
Oocytes | 1 | 1986 | 1169 | 0.020 |
Why?
|
Quality Improvement | 2 | 2019 | 3853 | 0.020 |
Why?
|
Cytoskeleton | 1 | 1986 | 1178 | 0.020 |
Why?
|
Disclosure | 1 | 2016 | 756 | 0.020 |
Why?
|
Social Conditions | 1 | 2011 | 119 | 0.020 |
Why?
|
Music Therapy | 1 | 2011 | 111 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 500 | 0.020 |
Why?
|
Health Plan Implementation | 1 | 2012 | 338 | 0.020 |
Why?
|
Fluid Therapy | 1 | 2013 | 584 | 0.020 |
Why?
|
United States Health Resources and Services Administration | 1 | 2008 | 14 | 0.020 |
Why?
|
Executive Function | 1 | 2017 | 1391 | 0.020 |
Why?
|
SEER Program | 1 | 2014 | 1446 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2015 | 1472 | 0.020 |
Why?
|
Personality | 1 | 2012 | 560 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3561 | 0.020 |
Why?
|
Feedback | 1 | 2012 | 796 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2008 | 7875 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2011 | 812 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6322 | 0.020 |
Why?
|
Training Support | 1 | 2008 | 109 | 0.020 |
Why?
|
Sample Size | 1 | 2011 | 845 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3312 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1158 | 0.020 |
Why?
|
Professional Practice | 1 | 2009 | 313 | 0.020 |
Why?
|
Cost Savings | 1 | 2012 | 904 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10070 | 0.020 |
Why?
|
Health Priorities | 1 | 2009 | 382 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13648 | 0.020 |
Why?
|
Social Values | 1 | 2006 | 224 | 0.020 |
Why?
|
Long-Term Care | 1 | 2009 | 629 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2015 | 2643 | 0.020 |
Why?
|
Operations Research | 1 | 2005 | 23 | 0.020 |
Why?
|
Financing, Government | 1 | 2008 | 473 | 0.010 |
Why?
|
Software Validation | 1 | 2005 | 59 | 0.010 |
Why?
|
Spouse Abuse | 1 | 2006 | 181 | 0.010 |
Why?
|
Software Design | 1 | 2005 | 173 | 0.010 |
Why?
|
Parity | 1 | 2008 | 931 | 0.010 |
Why?
|
Physical Examination | 1 | 2010 | 1266 | 0.010 |
Why?
|
Dietary Fats | 2 | 2002 | 2002 | 0.010 |
Why?
|
Postoperative Care | 1 | 2010 | 1470 | 0.010 |
Why?
|
Self-Help Groups | 1 | 2005 | 193 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4559 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6919 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 3076 | 0.010 |
Why?
|
Preventive Health Services | 1 | 2008 | 570 | 0.010 |
Why?
|
Length of Stay | 1 | 2017 | 6485 | 0.010 |
Why?
|
Attitude to Death | 1 | 2006 | 399 | 0.010 |
Why?
|
Neutropenia | 1 | 2008 | 893 | 0.010 |
Why?
|
Rural Population | 1 | 2014 | 2317 | 0.010 |
Why?
|
Health Status Disparities | 1 | 2014 | 1880 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4448 | 0.010 |
Why?
|
Hospital Information Systems | 1 | 2005 | 396 | 0.010 |
Why?
|
Breast Self-Examination | 1 | 2002 | 33 | 0.010 |
Why?
|
Prejudice | 1 | 2006 | 567 | 0.010 |
Why?
|
Causality | 1 | 2008 | 1248 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2015 | 5343 | 0.010 |
Why?
|
Primary Prevention | 1 | 2008 | 1187 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4850 | 0.010 |
Why?
|
Sex Distribution | 1 | 2005 | 2263 | 0.010 |
Why?
|
Benchmarking | 1 | 2006 | 1052 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2858 | 0.010 |
Why?
|
Leadership | 1 | 2009 | 1392 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 8067 | 0.010 |
Why?
|
New York City | 1 | 2002 | 733 | 0.010 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1135 | 0.010 |
Why?
|
Delphi Technique | 1 | 2003 | 893 | 0.010 |
Why?
|
Vaginal Smears | 1 | 2002 | 513 | 0.010 |
Why?
|
Dietary Fiber | 1 | 2002 | 767 | 0.010 |
Why?
|
Reference Values | 1 | 2005 | 4908 | 0.010 |
Why?
|
Diet Surveys | 1 | 2002 | 1159 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13039 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10729 | 0.010 |
Why?
|
Ambystoma | 1 | 1986 | 5 | 0.010 |
Why?
|
Vitamins | 1 | 2004 | 1630 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2002 | 3432 | 0.010 |
Why?
|
Immune Sera | 1 | 1986 | 601 | 0.010 |
Why?
|
Fertilization | 1 | 1986 | 197 | 0.010 |
Why?
|
Motor Activity | 1 | 2004 | 2704 | 0.010 |
Why?
|
Urban Population | 1 | 2002 | 2040 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14652 | 0.010 |
Why?
|
Obesity | 2 | 2008 | 13076 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 16047 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 1986 | 1325 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15398 | 0.000 |
Why?
|
Animals | 1 | 1986 | 168764 | 0.000 |
Why?
|